Filtered By:
Source: Arthritis Care and Research
Condition: Lupus
This page shows you your search results in order of date.
Order by Relevance | Date
Total 16 results found since Jan 2013.
Cerebrovascular Events in Systemic Lupus Erythematosus
ConclusionCerVEs, the fourth most frequent NP event in SLE, are usually attributable to lupus. In contrast to good physician reported outcomes, patients report a sustained reduction in health‐related quality of life following CerVEs.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - January 5, 2018 Category: Rheumatology Authors: John G. Hanly, Qiuju Li, Li Su, Murray B. Urowitz, Caroline Gordon, Sang ‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Sasha Bernatsky, Ann E. Clarke, Daniel J Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul Fortin, Dafna Tags: Original Article Source Type: research
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population ‐Based Study
Conclusion: Patients with SLE have an increased risk of cardiovascular events, particularly during the first year after diagnosis. Increased vigilance in monitoring for these potentially fatal outcomes and their modifiable risk factors is recommended in this patient population. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - January 26, 2017 Category: Rheumatology Authors: J. Antonio Avi ña‐Zubieta, Fergus To, Kateryna Vostretsova, Mary De Vera, Eric C. Sayre, John M. Esdaile Tags: Original Article Source Type: research
Disease Outcomes and Care Fragmentation among Patients with Systemic Lupus Erythematosus
Conclusion: In this cross‐site cohort of SLE patients, care fragmentation is associated with increased risk of severe infection and comorbidities. These results suggest that improved health information exchange could positively impact outcomes for SLE patients. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - November 30, 2016 Category: Rheumatology Authors: Theresa L. Walunas, Kathryn L. Jackson, Anh H. Chung, Karen A. Mancera ‐Cuevas, Daniel L. Erickson, Rosalind Ramsey‐Goldman, Abel Kho Tags: Original Article Source Type: research
Comorbidities in patients with Primary Sj ögren's Syndrome and Systemic Lupus Erythematosus: A comparative registries‐based study
Conclusions: pSS patients have consistently less serious CV comorbidity burden and a lower prevalence of severe infection than those with SLE. In contrast, their risk of lymphoma was greater. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - August 25, 2016 Category: Rheumatology Authors: I ñigo Rúa‐Figueroa, Mónica Fernández de Castro, José L. Andreu, Carlos Sanchez‐Piedra, Víctor Martínez‐Taboada, Alejandro Olivé, Javier López‐Longo, José Rosas, María Galindo, Jaime Calvo‐Alén, Antonio Fernández‐Nebro, Fernando A Tags: Original Article Source Type: research
Does Renin ‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study
ConclusionOur data do not support the hypothesis that ACE inhibitors/ARBs may be protective against atherosclerotic CVEs in LN patients.
Source: Arthritis Care and Research - August 18, 2016 Category: Rheumatology Authors: Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz Tags: Original Article Source Type: research
What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population‐Based Study of Maternal and Fetal Outcomes in SLE and Pre‐SLE
ConclusionOur data demonstrate that adverse maternal and fetal outcomes are more common in SLE pregnancies. Furthermore, these unfavorable outcomes are observed in pregnancies occurring prior to the diagnosis of SLE. Thus, the underlying immunologic profile of SLE and alterations preceding clinical SLE may contribute to these pregnancy complications.
Source: Arthritis Care and Research - June 22, 2016 Category: Rheumatology Authors: Elizabeth V. Arkema, Kristin Palmsten, Christopher Sjöwall, Elisabet Svenungsson, Jane E. Salmon, Julia F. Simard Tags: Systemic Lupus Erythematosus Source Type: research
What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population ‐Based Study of Maternal and Fetal Outcomes in SLE and Pre‐SLE
ConclusionOur data demonstrate that adverse maternal and fetal outcomes are more common in SLE pregnancies. Furthermore, these unfavorable outcomes are observed in pregnancies occurring prior to the diagnosis of SLE. Thus, the underlying immunologic profile of SLE and alterations preceding clinical SLE may contribute to these pregnancy complications.
Source: Arthritis Care and Research - June 22, 2016 Category: Rheumatology Authors: Elizabeth V. Arkema, Kristin Palmsten, Christopher Sj öwall, Elisabet Svenungsson, Jane E. Salmon, Julia F. Simard Tags: Systemic Lupus Erythematosus Source Type: research
Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999–2012
ConclusionPeople with SLE in the UK have a greater burden of comorbidity and are more likely to develop CVD, stroke, ESRF, cancer, osteoporosis, and infection than people of the same age and sex.
Source: Arthritis Care and Research - May 25, 2016 Category: Rheumatology Authors: Frances Rees, Michael Doherty, Matthew Grainge, Peter Lanyon, Graham Davenport, Weiya Zhang Tags: Systemic Lupus Erythematosus Source Type: research
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population‐based Cohort Study
Conclusion: CLE may be associated with an increased risk of CVA and PAD, but not IHD. Factors contributing to increase CVA risk in patients with CLE merit evaluation. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - March 24, 2016 Category: Rheumatology Authors: Abha G. Singh, Cynthia S. Crowson, Siddharth Singh, Mark Denis P. Davis, Hilal Maradit‐Kremers, Eric L. Matteson, Vaidehi R. Chowdhary Tags: Original Article Source Type: research
Does renin‐angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case‐control study
Conclusions: Our data do not support the hypothesis that ACEIs/ARBs may be protective against atherosclerotic CVEs in LN patients. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - February 11, 2016 Category: Rheumatology Authors: Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray B Urowitz Tags: Original Article Source Type: research
The burden of co‐morbidity in Systemic Lupus Erythematosus in the United Kingdom 1999‐2012
Conclusions: People with SLE in the UK have a greater burden of co‐morbidity and are more likely to develop CVD, stroke, ESRF, cancer, osteoporosis and infection than people of the same age and gender. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - October 16, 2015 Category: Rheumatology Authors: Frances Rees, Michael Doherty, Matthew Grainge, Peter Lanyon, Graham Davenport, Weiya Zhang Tags: Original Article Source Type: research
Racial and ethnic differences in mortality and cardiovascular events among patients with end‐stage renal disease due to lupus nephritis
Conclusion: Among patients with LN ESRD, Asians and Hispanics experienced lower mortality and CV event risks, while African Americans had higher mortality and CV event risks compared to Whites. This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - January 1, 2015 Category: Rheumatology Authors: Jose A. Gómez‐Puerta, Candace H. Feldman, Graciela S. Alarcón, Hongshu Guan, Wolfgang C. Winkelmayer, Karen H. Costenbader Tags: Original Article Source Type: research
Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature
ConclusionIt is difficult to determine the frequency of a “clinically significant aPL profile” in patients with aPL‐related clinical outcomes due to the lack of robust data. Our best estimates of the incidence of aPL‐associated events should be confirmed with appropriately designed population studies.
Source: Arthritis Care and Research - October 28, 2013 Category: Rheumatology Authors: Laura Andreoli, Cecilia B. Chighizola, Alessandra Banzato, Guillermo J. Pons‐Estel, Guilherme Ramire Jesus, Doruk Erkan, Tags: Brief Reports Source Type: research
Association of Systemic Lupus Erythematosus With a Higher Risk of Cervical but Not Trochanteric Hip Fracture: A Nationwide Population‐Based Study
ConclusionSLE is associated with a higher risk for cervical but not trochanteric HF, and these 2 types of HFs have different risk factors.
Source: Arthritis Care and Research - September 24, 2013 Category: Rheumatology Authors: Shu‐Hung Wang, Yu‐Sheng Chang, Chia‐Jen Liu, Chien‐Chih Lai, Wei‐Sheng Chen, Tzeng‐Ji Chen, Shuu‐Jiun Wang Tags: Systemic Lupus Erythematosus Source Type: research
The estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis
Conclusion: It is difficult to determine the frequency of a “clinically significant aPL profile” in patients with aPL‐related clinical outcomes due to the lack of robust data. Our best estimates of the incidence of aPL‐associated events should be confirmed with appropriately designed population studies. © 2013 American College of Rheumatology.
Source: Arthritis Care and Research - July 16, 2013 Category: Rheumatology Authors: Laura Andreoli, Cecilia B. Chighizola, Alessandra Banzato, Guillermo J. Pons‐Estel, Guilherme Ramires de Jesus, Doruk Erkan, Tags: Brief Report Source Type: research
